Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|July 1, 1980
Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillinD Kampf, R Schurig, K Weihermüller, et al.
Clinical Nephrology|January 1, 1983
Interactions between mezlocillin and sisomicin in vitro and in patients with normal and various degrees of impaired renal functionD Kampf, R Schurig, A Bergs, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1981
Cefoxitin pharmacokinetics: relation to three different renal clearance studies in patients with various degrees of renal insufficiencyD Kampf, R Schurig, I Korsukewitz, et al.
Neuroradiology|January 1, 1980
Clinical dosimetry during cerebral arteriographyM Chopp, H D Portnoy, R Schurig, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1979
Central and peripheral haemodynamics in longterm peritoneal dialysis patientsR Schurig, G Gahl, M Schartl, et al.
Zeitschrift Fur Gastroenterologie|September 1, 1982
[Effect of diffusion potentials and various stomach regions on the behavior of the potential difference after pentagastrin]D von Kleist, K Langner, R Schurig, et al.
Artificial Organs|August 1, 1979
Hemodynamic studies in long-term peritoneal dialysis patientsR Schurig, G M Gahl, H Becker, et al.
Schweizerische Medizinische Wochenschrift|December 29, 1979
[Continous ambulatory peritoneal dialysis (CAPD)]G M Gahl, H Becker, R Schurig, et al.
Annals of Internal Medicine|May 1, 1981
Outpatient evaluation of dietary intake and nitrogen removal in continuous ambulatory peritoneal dialysisG M Gahl, H V Baeyer, R Averdunk, et al.
The International Journal of Artificial Organs|July 1, 1980
Clinical and metabolic aspects of continuous ambulatory peritoneal dialysis (CAPD)G M Gahl, R Schurig, H Becker, et al.
Pageof 1